机译:肝动脉输注化疗联合免疫检查点抑制剂和酪氨酸激酶抑制剂治疗晚期肝细胞癌的疗效和安全性:系统评价和荟萃分析
Department of Oncology, Nanjing Jinling Hospital of Nanjing University, Nanjing, Jiangsu 210002, P;
adverse events; hepatic arterial infusion chemotherapy; hepatocellular carcinoma; immune checkpoint inhibitors; tyrosine kinase inhibitors.;
机译:Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients
机译:Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment of Large Hepatocellular Carcinoma
机译:Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib alone for advanced hepatocellular carcinoma: A systematic review and meta‐analysis
机译:advanced hepatocellular carcinoma treated effectively with irinotecan via hepatic arterial infusion followed by proton beam therapy